Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-12

Clinical Trial Update: Re-irradiation of High Grade Gliomas: a Quality of Life Study

View source ↗

Summary

A clinical trial studying re-irradiation for high-grade gliomas with a quality-of-life focus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Anaplastic Astrocytoma, Glioblastoma Multiforme | Status: WITHDRAWN